A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease, according to a new study published in PLOS ONE by researchers from the University of Eastern Finland together with international collaborators. In the study, the researchers describe a novel nuclear acting microRNA. MicroRNAs are small RNA molecules, which […]
Read More… from Novel nuclear microRNA for treatment of cardiovascular disease